Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-04-09Clinical Trial Update: A Study in Patients With Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma [Phase 2]
A Phase 2 study sponsored by Eli Lilly in patients with persistent or recurrent epithelial ovarian cancer or primary peritoneal carcinoma ha…
-
CLINICAL_TRIALS trial_result · 2010-04-08Clinical Trial Update: Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer [Phase 2]
Phase II trial evaluating an EGFR-targeted therapy in patients with advanced ovarian, primary peritoneal, and fallopian tube cancers; the st…
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors [Phase 2]
Phase 2 trial update evaluating Interleukin-11 plus filgrastim as a pre-transplant regimen for patients undergoing peripheral stem cell tran…
-
CLINICAL_TRIALS trial_result · 2010-03-24Clinical Trial Update: Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries [NA]
A completed clinical trial assessing fenretinide for preventing ovarian cancer in women at high risk (BRCA1/BRCA2 carriers) undergoing oopho…
-
CLINICAL_TRIALS trial_result · 2010-03-17Clinical Trial Update: Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer [Phase 2]
Phase 2 trial evaluating fulvestrant for recurrent ovarian epithelial cancer has completed with results posted in 2010.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: Aromasin (Exemestane) in Patients With Recurrent or Refractory Stage II - IV Epithelial Ovarian Cancer [Phase 2]
Phase 2 trial of exemestane (Aromasin) in patients with recurrent or refractory stage II-IV epithelial ovarian cancer; the study status is c…
-
CLINICAL_TRIALS trial_result · 2010-02-26Clinical Trial Update: CT-2106 for the Second Line Treatment of Ovarian Cancer [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating CT-2106 as second-line therapy for ovarian cancer. It notes CTI …
-
CLINICAL_TRIALS trial_result · 2010-02-22Clinical Trial Update: Study of XL999 in Patients With Previously Treated Ovarian Cancer [Phase 2]
A Phase 2 study of XL999 in previously treated ovarian cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2010-02-08Clinical Trial Update: Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial evaluating carboplatin, paclitaxel, and surgery for advanced ovarian epithelial, fallopian tube, or primary peritoneal cancer;…
-
CLINICAL_TRIALS trial_result · 2010-02-03Clinical Trial Update: Fragmin in Ovarian Cancer: Utility on Survival (FOCUS) [Phase 2]
Phase 2 trial FOCUS evaluated dalteparin (Fragmin) for potential survival benefit in ovarian cancer; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2010-02-01Clinical Trial Update: Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema
Completed clinical trial evaluating a gynecologic cancer lymphedema questionnaire as a tool to identify lower-extremity lymphedema in patien…
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer [Phase 2]
Phase 2 trial evaluating fondaparinux to prevent blood clots in patients undergoing surgery for gynecologic cancer has completed with result…
-
CLINICAL_TRIALS trial_result · 2010-01-13Clinical Trial Update: Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function [Phase 1]
Phase 1 trial assessing safety and dosage of docetaxel in patients with solid tumors and abnormal liver function. The study includes breast …
-
CLINICAL_TRIALS trial_result · 2010-01-07Clinical Trial Update: Evaluating Tools for Health Promotion and Disease Prevention [Phase 1]
This clinical trial update notes the completion of a Phase 1 study sponsored by the CDC evaluating tools for health promotion and disease pr…
-
CLINICAL_TRIALS trial_result · 2009-12-15Clinical Trial Update: Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer [Phase 1]
A Phase 1 trial evaluated the maximum tolerated dose of lapatinib in combination with carboplatin for recurrent ovarian cancer. The study ha…
-
CLINICAL_TRIALS trial_result · 2009-11-26Clinical Trial Update: Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer [Phase 2]
Phase 2 study funded by GlaxoSmithKline evaluating a second-line therapy for potentially platinum-sensitive relapsed ovarian cancer; results…
-
CLINICAL_TRIALS trial_result · 2009-10-29Clinical Trial Update: Efficacy and Safety of Subsequent Cisplatin and Docetaxel in Ovarian Cancer [Phase 2]
A Phase 2 study assessing the effectiveness and safety of sequential cisplatin and docetaxel chemotherapy in ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2009-09-25Clinical Trial Update: Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers [Phase 2]
A Phase 2 study evaluating an immune response modifier for breast, ovarian, endometrial, and cervical cancers has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2009-09-24Clinical Trial Update: A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors [Phase 1]
Phase 1 trial comparing oral picoplatin with intravenous picoplatin in patients with solid tumors has been completed, evaluating safety and …
-
CLINICAL_TRIALS trial_result · 2009-08-24Clinical Trial Update: A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer [Phase 2]
Phase 2 study of single-agent pemetrexed disodium in patients with recurrent or persistent ovarian cancer or primary peritoneal cancer; resu…
-
CLINICAL_TRIALS trial_result · 2009-07-20Clinical Trial Update: Genetic Studies in Breast Cancer
An update on genetic studies related to breast cancer (with ovarian cancer as a listed condition) from Memorial Sloan Kettering Cancer Cente…
-
CLINICAL_TRIALS trial_result · 2009-06-04Clinical Trial Update: Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer [Phase 2]
Phase 2 trial update showing safety and preliminary efficacy of S-8184 as second-line therapy for stage III/IV ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2009-05-18Clinical Trial Update: Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial of docetaxel and capecitabine in recurrent or persistent ovarian epithelial cancer, fallopian tube cancer, and peritoneal canc…
-
CLINICAL_TRIALS trial_result · 2009-04-30Clinical Trial Update: Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer [Phase 2]
Phase 2 clinical trial evaluating whole-body hyperthermia in combination with chemotherapy for metastatic breast, ovarian, endometrial, or c…
-
CLINICAL_TRIALS trial_result · 2009-04-28Clinical Trial Update: Efficacy of Topotecan and Lapatinib in Early Recurrent Ovarian or Peritoneal Cancer [Phase 2]
A Phase 2 trial evaluating the combination of topotecan and lapatinib in patients with early recurrent ovarian or peritoneal cancer has been…